Amy S. Major

3.5k total citations · 1 hit paper
57 papers, 2.7k citations indexed

About

Amy S. Major is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Amy S. Major has authored 57 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 14 papers in Rheumatology and 13 papers in Molecular Biology. Recurrent topics in Amy S. Major's work include Atherosclerosis and Cardiovascular Diseases (37 papers), T-cell and B-cell Immunology (17 papers) and Immune Cell Function and Interaction (14 papers). Amy S. Major is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (37 papers), T-cell and B-cell Immunology (17 papers) and Immune Cell Function and Interaction (14 papers). Amy S. Major collaborates with scholars based in United States, Netherlands and Brazil. Amy S. Major's co-authors include MacRae F. Linton, Sergio Fazio, Jillian P. Rhoads, Ashley J. Wilhelm, Larry L. Swift, Patricia G. Yancey, Jeffrey C. Rathmell, Vladimir R. Babaev, Roman Covarrubias and Yanice Mendez-Fernandez and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Amy S. Major

56 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-fat diet–induced colonocyte dysfunction escalates microbiota-derived trimethylamine N -oxide

2021 217 citations Jeffrey C. Rathmell, Amy S. Major et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy S. Major United States	27	1.3k	857	750	453	413	57	2.7k
Agnès Boullier France	26	1.7k 1.3×	967 1.1×	558 0.7×	632 1.4×	262 0.6×	56	3.3k
Paul C. Dimayuga United States	27	1.2k 0.9×	518 0.6×	460 0.6×	395 0.9×	259 0.6×	53	2.2k
Tessa J. Barrett United States	28	1.2k 0.9×	864 1.0×	597 0.8×	427 0.9×	143 0.3×	62	2.7k
Flore Mulhaupt Switzerland	8	728 0.5×	638 0.7×	671 0.9×	324 0.7×	255 0.6×	9	2.1k
Kathrin Eller Austria	30	828 0.6×	666 0.8×	622 0.8×	464 1.0×	150 0.4×	138	3.2k
Virgilio Evangelista Italy	34	927 0.7×	883 1.0×	429 0.6×	268 0.6×	216 0.5×	75	3.9k
Mats Rudling Sweden	24	859 0.6×	1.1k 1.2×	1.2k 1.6×	601 1.3×	134 0.3×	44	3.1k
Mikko P.S. Ares Sweden	22	789 0.6×	511 0.6×	412 0.5×	408 0.9×	161 0.4×	32	1.8k
Mi-Kyung Chang United States	16	3.5k 2.6×	1.0k 1.2×	644 0.9×	1.1k 2.4×	668 1.6×	18	4.4k
Shiro Kitamoto Japan	31	1.2k 0.9×	1.3k 1.6×	762 1.0×	451 1.0×	182 0.4×	52	3.8k

Countries citing papers authored by Amy S. Major

Since Specialization

Citations

This map shows the geographic impact of Amy S. Major's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy S. Major with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy S. Major more than expected).

Fields of papers citing papers by Amy S. Major

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy S. Major. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy S. Major. The network helps show where Amy S. Major may publish in the future.

Co-authorship network of co-authors of Amy S. Major

This figure shows the co-authorship network connecting the top 25 collaborators of Amy S. Major. A scholar is included among the top collaborators of Amy S. Major based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy S. Major. Amy S. Major is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leuven, Sander I. van, Lenny van Bon, Robin Nijveldt, & Amy S. Major. (2025). Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion. Rheumatology Advances in Practice. 9(2). rkaf048–rkaf048. 1 indexed citations

Leuven, Sander I. van & Amy S. Major. (2023). Accelerated atherosclerosis in systemic lupus erythematosus: don’t forget the devil we know!. Lara D. Veeken. 63(1). 3–5. 1 indexed citations

Wilson, Christopher, et al.. (2021). Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice. JCI Insight. 6(19). 14 indexed citations

Williams, Charles H., et al.. (2020). <p>PEGylated PLGA Nanoparticle Delivery of Eggmanone for T Cell Modulation: Applications in Rheumatic Autoimmunity</p>. International Journal of Nanomedicine. Volume 15. 1215–1228. 15 indexed citations

Rhoads, Jillian P., et al.. (2019). FcγRIIb on CD11c+ cells modulates serum cholesterol and triglyceride levels and differentially affects atherosclerosis in male and female Ldlr mice. Atherosclerosis. 285. 108–119. 10 indexed citations

Rhoads, Jillian P., Amy S. Major, & Jeffrey C. Rathmell. (2017). Fine tuning of immunometabolism for the treatment of rheumatic diseases. Nature Reviews Rheumatology. 13(5). 313–320. 63 indexed citations

Covarrubias, Roman, Ashley J. Wilhelm, & Amy S. Major. (2014). Specific Deletion of LDL Receptor-Related Protein on Macrophages Has Skewed In Vivo Effects on Cytokine Production by Invariant Natural Killer T Cells. PLoS ONE. 9(7). e102236–e102236. 11 indexed citations

Giunzioni, Ilaria, Hagai Tavori, Roman Covarrubias, et al.. (2013). Abstract 19083: Macrophage Expression of Pcsk9 Influences Atherosclerosis Development. Circulation. 128(suppl_22). 1 indexed citations

Yu, Fang, Fen Du, Yuzhen Wang, et al.. (2013). Bone Marrow Deficiency of MCPIP1 Results in Severe Multi-Organ Inflammation but Diminishes Atherogenesis in Hyperlipidemic Mice. PLoS ONE. 8(11). e80089–e80089. 15 indexed citations

10.

Mendez-Fernandez, Yanice, Cody J. Diehl, Nicole Braun, et al.. (2010). The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE−/− mice. Atherosclerosis. 214(1). 73–80. 46 indexed citations

11.

Wilhelm, Ashley J., Manal Zabalawi, J.S. Owen, et al.. (2010). Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr−/−, ApoA-I−/− Mice. Journal of Biological Chemistry. 285(46). 36158–36169. 108 indexed citations

12.

Leuven, Sander I. van, Yanice Mendez-Fernandez, Erik S.G. Stroes, Paul P. Tak, & Amy S. Major. (2010). Statin therapy in lupus-mediated atherogenesis: two birds with one stone?. Annals of the Rheumatic Diseases. 70(2). 245–248. 26 indexed citations

13.

Lorton, Dianne, Cheri Lubahn, Sarah Sweeney, et al.. (2008). Differences in the injury/sprouting response of splenic noradrenergic nerves in Lewis rats with adjuvant-induced arthritis compared with rats treated with 6-hydroxydopamine. Brain Behavior and Immunity. 23(2). 276–285. 24 indexed citations

14.

Stanic, Aleksandar K., Charles Stein, Sergio Fazio, et al.. (2006). Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proceedings of the National Academy of Sciences. 103(18). 7018–7023. 67 indexed citations

15.

Babaev, Vladimir R., Patricia G. Yancey, Amy S. Major, et al.. (2005). Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. Journal of Molecular and Cellular Cardiology. 39(3). 443–452. 90 indexed citations

16.

Su, Yan, Hiroyuki Ishiguro, Amy S. Major, et al.. (2003). Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-Deficient mice and up-regulates ABC transporters. Molecular Therapy. 8(4). 576–583. 22 indexed citations

17.

Fazio, Sergio, et al.. (2002). Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice. Journal of Lipid Research. 43(10). 1602–1609. 47 indexed citations

18.

Ishiguro, Hiroyuki, Hiroaki Yoshida, Amy S. Major, et al.. (2001). Retrovirus-mediated Expression of Apolipoprotein A-I in the Macrophage Protects against Atherosclerosis in Vivo. Journal of Biological Chemistry. 276(39). 36742–36748. 41 indexed citations

19.

Swift, Larry L., et al.. (2001). A Recycling Pathway for Resecretion of Internalized Apolipoprotein E in Liver Cells. Journal of Biological Chemistry. 276(25). 22965–22970. 51 indexed citations

20.

Fazio, Sergio, Amy S. Major, Larry L. Swift, et al.. (2001). Increased atherosclerosis in LDL receptor–null mice lacking ACAT1 in macrophages. Journal of Clinical Investigation. 107(2). 163–171. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact